Publications by authors named "Eli Marom"

Claim this Profile
T
Trends in compassionate use of medicinal products: Israel 2020-2024.
Eyal Schwartzberg, Eli Marom, Victoria Finkel-Pekarsky, Segev Shani, Miriam Cohen Kandli

Isr J Health Policy Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug shortages in Israel, revisited: a bitter pill to swallow.
Eyal Schwartzberg, Eli Marom, Alla Vishkautzan, Einat Gorelik, Segev Shani

Isr J Health Policy Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[ETHICAL PERSPECTIVES AND DILEMMAS IN PRESCRIBING AND DISPENSING MEDICINAL PRODUCTS IN ISRAEL].
Eyal Schwartzberg, Eli Marom, Miri Trainin, Ophir Lavon, Segev Shani

Harefuah· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA.
Stephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, Ilana Weiss, Shai Ashkenazi, Eli Marom

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance in food-producing animals: towards implementing a one health based national action plan in Israel.
Tali Sarah Berman, Zohar Barnett-Itzhaki, Tamar Berman, Eli Marom

Isr J Health Policy Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacy in Israel versus the US, can we "compare apples to apples"?-commentary.
Eyal Schwartzberg, Eli Marom

Isr J Health Policy Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and other specialty services offered by pharmacists in the community: the international arena and Israel.
Eyal Schwartzberg, Joseph P Nathan, Sivan Avron, Eli Marom

Isr J Health Policy Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
Alexander M Ponizovsky, Eli Marom, Abraham Weizman, Eyal Schwartzberg

Pharmacoepidemiol Drug Saf· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy in Israel.
Eyal Schwartzberg, Joseph P Nathan, Bruce Rosen, Eli Marom

Am J Health Syst Pharm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in utilization of benzodiazepine and Z-drugs in Israel.
Erez Berman, Sara Eyal, Eli Marom

Pharmacoepidemiol Drug Saf· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for patient empowerment through the promotion of medicines in Israel: regulatory framework for the pharmaceutical industry.
Eyal Schwartzberg, Zohar Barnett-Itzhaki, Itamar Grotto, Eli Marom

Isr J Health Policy Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
Nicola Maggio, Maria Firer, Huda Zaid, Yana Bederovsky, Mohammed Aboukaoud, Eli Marom

J Clin Pharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.
Shoshana Israel, Nicola Maggio, Dana Ekstein, Huda Zaid, Maria Firer, Eli Marom

Epilepsia· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of antiepileptic drugs in Israel.
Erez Berman, Eli Marom, Dana Ekstein, Ilan Blatt, Sara Eyal

Epilepsy Behav· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013.
Alexander M Ponizovsky, Eli Marom, Michal Ben-Laish, Igor Barash, Abraham Weizman

Isr J Health Policy Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012.
Alexander M Ponizovsky, Eli Marom, Israel Fitoussi

Pharmacoepidemiol Drug Saf· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the consumption rates and regulatory barriers to the accessibility of strong opioid analgesics in Israel and St. Petersburg.
Alexander M Ponizovsky, Michael V Pchelintsev, Eli Marom, Edwin E Zvartau

Eur J Clin Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Synthetic cannabinoids--the new "legal high" drugs].
Ronny Berkovitz, Mickey Arieli, Eli Marom

Harefuah· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychotropic drug use in Israel: results from the national health survey.
Alexander Grinshpoon, Eli Marom, Abraham Weizman, Alexander M Ponizovsky

Prim Care Companion J Clin Psychiatry· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in opioid analgesics consumption, Israel, 2000-2008.
Alexander M Ponizovsky, Eli Marom, Alexander Zeldin, Nathan I Cherny

Eur J Clin Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The over the counter drugs reform in Israel--two years later].
Sharona Vaknin, Ifat Abadi-Korek, Eli Marom, Joshua Shemer, Osnat Luxenburg

Harefuah· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Over the counter drugs--a new era in Israel].
Ifat Abadi-Korek, Sharona Vaknin, Eli Marom, Joshua Shemer, Osnat Luxenburg

Harefuah· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
Orly Tamir, Naomi Friedman, Sharon Furman-Assaf, Eli Marom, Mickey Arieli

Harefuah· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
Sharon Furman-Assaf, Orly Tamir, Eli Marom, Mickey Arieli, Joshua Shemer

Harefuah· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis